Human Genome Epidemiology Literature Finder
Records 1 - 15 (of 15 Records) |
Query Trace: Recurrence and CDK4[original query] |
---|
Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1. Breast cancer research and treatment 2008 Jan 107 (1): 95-102. Yu Cheng-Ping, Yu Jyh-Cherng, Sun Chien-An, Tzao Ching, Ho Jar-Yi, Yen Amy Ming-Fa |
Copy number analysis of 24 oncogenes: MDM4 identified as a putative marker for low recurrence risk in non muscle invasive bladder cancer. International journal of molecular sciences 2014 15 (7): 12458-68. Salvi Samanta, Calistri Daniele, Gurioli Giorgia, Carretta Elisa, Serra Luigi, Gunelli Roberta, Zoli Wainer, Casadio Valenti |
Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer. Oncotarget 2016 Sep 7 (38): 61575-61586. van Ginkel Joost H, de Leng Wendy W J, de Bree Remco, van Es Robert J J, Willems Stefan |
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial. The Lancet. Oncology 2016 Mar . Cristofanilli Massimo, Turner Nicholas C, Bondarenko Igor, Ro Jungsil, Im Seock-Ah, Masuda Norikazu, Colleoni Marco, DeMichele Angela, Loi Sherene, Verma Sunil, Iwata Hiroji, Harbeck Nadia, Zhang Ke, Theall Kathy Puyana, Jiang Yuqiu, Bartlett Cynthia Huang, Koehler Maria, Slamon Denn |
Epidemiology and genetic susceptibility of malignant melanoma in North Sardinia, Italy. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2016 Mar . Cossu Antonio, Casula Milena, Cesaraccio Rosaria, Lissia Amelia, Colombino Maria, Sini Maria C, Budroni Mario, Tanda Francesco, Paliogiannis Panagiotis, Palmieri Giusep |
A gene expression signature of retinoblastoma loss-of-function is a predictive biomarker of resistance to palbociclib in breast cancer cell lines and is prognostic in patients with ER positive early breast cancer. Oncotarget 2016 Sep 7 (42): 68012-68022. Malorni Luca, Piazza Silvano, Ciani Yari, Guarducci Cristina, Bonechi Martina, Biagioni Chiara, Hart Christopher D, Verardo Roberto, Di Leo Angelo, Migliaccio Ilen |
High-grade Müllerian Adenosarcoma: Genomic and Clinicopathologic Characterization of a Distinct Neoplasm With Prevalent TP53 Pathway Alterations and Aggressive Behavior. The American journal of surgical pathology 2017 Aug . Hodgson Anjelica, Amemiya Yutaka, Seth Arun, Djordjevic Bojana, Parra-Herran Carl |
Detailed genomic characterization identifies high heterogeneity and histotype-specific genomic profiles in adrenocortical carcinomas. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2018 Mar . Vatrano Simona, Volante Marco, Duregon Eleonora, Giorcelli Jessica, Izzo Stefania, Rapa Ida, Votta Arianna, Germano Antonina, Scagliotti Giorgio, Berruti Alfredo, Terzolo Massimo, Papotti And Mau |
Genetic alterations in epidermal growth factor receptor-tyrosine kinase inhibitor-naïve non-small cell lung carcinoma. Oncology letters 2020 5 19 (6): 4169-4176. Yamaura Takumi, Muto Satoshi, Mine Hayato, Takagi Hironori, Watanabe Masayuki, Ozaki Yuki, Inoue Takuya, Fukuhara Mitsuro, Okabe Naoyuki, Matsumura Yuki, Hasegawa Takeo, Osugi Jun, Hoshino Mika, Higuchi Mitsunori, Shio Yutaka, Suzuki Hiroyu |
Genomic characterization reveals potential biomarkers in nasopharyngeal carcinoma patients with relapse. Expert review of molecular diagnostics 2020 10 20 (11): 1149-1159. Cho William C S, Tse Ka-Po, Ngan Roger K C, Cheuk Wah, Ma Victor W S, Yang Yi-Ting, Yip Timothy T C, Tan Kien Thiam, Chen Shu-J |
Genetic profile and immunohistochemical study of clear cell renal carcinoma: Pathological-anatomical correlation and prognosis. Cancer treatment and research communications 2021 5 27 100374. Diez-Calzadilla N A, Noguera Salvá R, Soriano Sarrió P, Martínez-Jabaloyas J |
CCND1 Copy Number Variation in Circulating Tumor DNA from Luminal B Breast Cancer Patients. Anticancer research 2022 7 42 (8): 4071-4077. Shimazaki Akiko, Kubo Makoto, Kurata Kanako, Takao Yuka, Hayashi Saori, Harada Yurina, Kawaji Hitomi, Kaneshiro Kazuhisa, Yamada Mai, Kai Masaya, Nakamura Masafu |
The clinicopathological and molecular characteristics of resected EGFR-mutant lung adenocarcinoma. Cancer medicine 2022 1 11 (5): 1299-1309. Zhou Wensheng, Liu Zhichao, Wang Yanan, Zhang Yanwei, Qian Fangfei, Lu Jun, Wang Huimin, Gu Ping, Hu Minjuan, Chen Ya, Yang Zhengyu, Zhao Ruiying, Lou Yuqing, Han Baohui, Zhang W |
Alternating 17?-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 6 OF1-OF7. Gary N Schwartz, Peter A Kaufman, Karthik V Giridhar, Jonathan D Marotti, Mary D Chamberlin, Bradley A Arrick, Grace Makari-Judson, Matthew P Goetz, Shannon M Soucy, Fred Kolling, Eugene Demidenko, Todd W Mill |
TIROSEC: Molecular, Clinical and Histopathological Profile of Papillary Thyroid Carcinoma in a Colombian Cohort. Advances in therapy 2024 1 . Sergio D Cruz-Romero, Sebastián González, José Y Juez, David S Becerra, Ana M Baldión, José A Hakim, Deyanira González-Devia, Sandra Perdomo, Paula A Rodríguez-Urre |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: